Navigation Links
Sanofi-aventis Delivers 2008 Results Above Guidance
Date:2/11/2009

705 +9.9% 6,143 +15.3%

Full-year 2008 sales of Plavix(R) in the United States (consolidated by BMS) were sharply higher than in 2007, when sales were affected by competition from a generic version in the early part of the year. In Europe, the product's 3.2% growth rate reflected competition from several clopidogrel besylates in the monotherapy segment since August in Germany, where the market share of Plavix(R)/Iscover(R) by volume remained around 75% in December (IMS Pharmatrend, week commencing December 22, 2008). In the "Other Countries" region, growth for Plavix(R) benefited from its success in Japan, where net sales reached EUR 67 million in the fourth quarter of 2008 (vs. EUR 33 million in the fourth quarter of 2007) and EUR 182 million over 2008 as a whole (vs. EUR 66 million in 2007).

Worldwide presence(1) of Aprovel(R)/Avapro(R)/Karvea(R)

    EUR million                        Change on a            Change on a
                                       comparable             comparable
                                Q4 2008    basis     FY 2008     basis
    Europe                        250        +9.2%     992        +8.8%
    United States                 140        +2.2%     499        +6.4%
    Other Countries               120        +4.3%     475       +20.6%
    TOTAL                         510        +6.0%   1,966       +10.8%

Despite a very competitive environment, worldwide sales of Aprovel(R) achieved double-digit growth in 2008.

(1) See appendix 7 for a definition of financial indicators

In September 2008, the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on the authorization of a generic of irbesartan as a monotherapy in Europe. However, the active ingredient of
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
2. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
3. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
4. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
5. Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
6. Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
7. Sanofi-aventis Teams With HHS Quality Agency to Distribute Consumer Health Materials
8. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
9. Sanofi-aventis: Encouraging First-Quarter 2008 Results Further Positive Phase III Results for Eplivanserin
10. TechTeam Global Will Provide Multilingual EDC Support Services for sanofi-aventis recherche & developpement
11. Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... 2015 , ... When Walker Parking Consultants specified Kenall Manufacturing ... they knew it would save the university energy and maintenance costs. What they ... energy savings after installation was an impressive 89 percent, which resulted in the ...
(Date:7/2/2015)... ... ... summer in full swing, Americans are flocking to Canada’s many lakes to reel in their ... the world, and it’s easy to understand why. From the Pacific Northwest Coast of British ... fishing is a huge industry, and Americans make up the vast majority of anglers from ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech ... a technology expert and special reporter for NewsWatch, conducted the review and shared with ... market. , According to the U.S. Department of Energy, it’s very important to use ...
(Date:7/2/2015)... PEACHTREE CITY, GA (PRWEB) , ... July 02, ... ... or field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the ... physicians, fitness experts and athletic trainers. Their significant popularity has inspired four new, ...
(Date:7/2/2015)... ... 02, 2015 , ... Six months ahead of his 80th birthday, Don Stevenson ... and money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk in ... D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making his way ...
Breaking Medicine News(10 mins):Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... asked to investigate Australia’s crippled mental health services and ... that the funding would triple for Australia's mental health ... set up if the Government accepts the demands of ... release mental health patients from institutions into the community. ...
... long waiting lists. He said that they can take their health ... He guaranteed that one can open the door to legal action ... , By this the framework in place is maintained ... care that is essential. Clement said this while, speaking at a ...
... The device, which is used for treating obstructive sleep apnea ... to be beneficial in resolving heart abnormalities, says Belgium physicians. ... that pump less effectively. ,"Not only are ... side of the heart was dilated and the heart muscle ...
... the alleged leak of question papers of the MD/MS and ... Institute of Medical Sciences (AIIMS), // has been identified ... Medical College. ,Satish Kumar (26),an MD (Paediatric) student, ... two other doctors have been taken into custody by ...
... would be targeted towards controlling the spread of three ... are haunting the Asian region. Furthermore, a 'Programme for ... Action' would be launched neat year. ,The main focus ... financial constraints that prevent the realization of the sixth ...
... announced on Thursday about its overseas expansion of acquiring ... ,This is the fourth acquisition announced by the ... takeover of Romania's Terapia for $324 million, GlaxoSmithKline Plc's ... and assets to Senetek Plc's auto-injector device by the ...
Cached Medicine News:Health News:Control And Prevention Of Three Diseases To Be Discussed: European Commission 2
(Date:7/2/2015)... , July 2, 2015 According to ... Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), ... Global Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation ... projected to reach $6.20 Billion by 2020, at a CAGR ... 8 4 market data T ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced the addition ... Application - Forecast to 2020" report to their offering. ... Billion in 2020 from an estimated $7.1 Billion in 2015, growing ... by North America , followed by ... the World (RoW). The cancer diagnostics market in Asia ...
(Date:7/2/2015)... SAN FRANCISCO , July 2, 2015  The ... www.tryloud.com ), the world,s first HIPAA compliant mobile app ... delivery of farm-to-table fresh medical marijuana, announced today that ... Unlike Eaze, Meadow and more than half ... in the last year, Loud Cannabis is unique in ...
Breaking Medicine Technology:Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2
... analysis shows nearly nine out of ten patients ... of 12 months, WASHINGTON, D.C., May 22, 2007 ... extension study (303),presented at the British Society of ... showed Shire plc's,Lialda(mesalamine) is well tolerated in mild ...
... Sustained Response and Remission in,Follow-up to Phase 1 ... Patients with IV Steroid-Refractory Ulcerative Colitis, FREMONT, Calif., ... Digestive Disease Week (DDW) meeting this week in,Washington ... Clinic,suggest that Nuvion (visilizumab), an antibody in development ...
Cached Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 2PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 3PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 4PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007,Digestive Disease Week 5
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
The link classic plus hip stem for cemented primary hip replacement surgery...
The uncemented hip joint prosthesis system...
The Quatroloc primary hip system offers 35 primary stems to fit almost all femurs for primary hip arthroplasty....
Medicine Products: